|
1
|
Zhai B, Chen P, Wang W, Liu S, Feng J,
Duan T, Xiang Y, Zhang R, Zhang M, Han X, et al: An
ATF24 peptide-functionalized β-elemene-nanostructured
lipid carrier combined with cisplatin for bladder cancer treatment.
Cancer Biol Med. 17:676–692. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou J, Kang Y, Gao Y, Ye XY, Zhang H and
Xie T: β-Elemene inhibits epithelial-mesenchymal transformation in
non-small cell lung cancer by targeting ALDH3B2/RPSA axis. Biochem
Pharmacol. 232:1167092025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zraik IM and Heß-Busch Y: Management of
chemotherapy side effects and their long-term sequelae. Urologe A.
60:862–871. 2021.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaudary N, Hill RP and Milosevic M:
Targeting the CXCL12/CXCR4 pathway to reduce radiation treatment
side effects. Radiother Oncol. 194:1101942024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S,
Xiang Y, Zhang M, Pan T, Chen X, et al: Erianin, a novel dibenzyl
compound in Dendrobium extract, inhibits lung cancer cell growth
and migration via calcium/calmodulin-dependent ferroptosis. Signal
Transduct Target Ther. 5:512020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai R, Zhu J, Bai Z, Mao Q, Zhang Y, Hui
Z, Luo X, Ye XY and Xie T: Second generation β-elemene nitric oxide
derivatives with reasonable linkers: Potential hybrids against
malignant brain glioma. J Enzyme Inhib Med Chem. 37:379–385. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu SX, Liang ZM, Wu QB, Shou L, Huang XX,
Zhu QR, Xie H, Mei RY, Zhang RN, Zhai XY, et al: A novel diagnostic
and therapeutic strategy for cancer patients by integrating Chinese
medicine syndrome differentiation and precision medicine. Chin J
Integr Med. 28:867–871. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan T, Feng Y, Wang W, Wang R, Yin L, Zeng
Y, Zeng Z and Xie T: Cabazitaxel-loaded human serum albumin
nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for
the treatment of paclitaxel-resistant non-small cell lung cancer.
Cancer Nanotechnol. 14:702023. View Article : Google Scholar
|
|
10
|
Xu YX, Chen YM, Zhang MJ, Ren YY, Wu P,
Chen L, Zhang HM, Zhou JL and Xie T: Screening of anti-cancer
compounds from Vaccariae Semen by lung cancer A549 cell fishing and
UHPLC-LTQ Orbitrap MS. J Chromatogr B Analyt Technol Biomed Life
Sci. 1228:1238512023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sui X, Zhang M, Han X, Zhang R, Chen L,
Liu Y, Xiang Y and Xie T: Combination of traditional Chinese
medicine and epidermal growth factor receptor tyrosine kinase
inhibitors in the treatment of non-small cell lung cancer: A
systematic review and meta-analysis. Medicine (Baltimore).
99:e206832020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Zeng H, You Y, Wang R, Tan T, Wang
W, Yin L, Zeng Z, Zeng Y and Xie T: Active targeting of orthotopic
glioma using biomimetic liposomes co-loaded elemene and cabazitaxel
modified by transferritin. J Nanobiotechnology. 19:2892021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu S, Li Q, Li G, Zhang Q, Zhuo L, Han X,
Zhang M, Chen X, Pan T, Yan L, et al: The mechanism of
m6A methyltransferase METTL3-mediated autophagy in
reversing gefitinib resistance in NSCLC cells by β-elemene. Cell
Death Dis. 11:9692020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen P, Li X, Zhang R, Liu S, Xiang Y,
Zhang M, Chen X, Pan T, Yan L, Feng J, et al: Combinative treatment
of β-elemene and cetuximab is sensitive to KRAS mutant colorectal
cancer cells by inducing ferroptosis and inhibiting
epithelial-mesenchymal transformation. Theranostics. 10:5107–5119.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Q, Feng J, Liu W, Wen C, Wu Y, Liao Q,
Zou L, Sui X, Xie T, Zhang J and Hu Y: Opportunities and challenges
for co-delivery nanomedicines based on combination of
phytochemicals with chemotherapeutic drugs in cancer treatment. Adv
Drug Deliv Rev. 188:1144452022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo X, Wen T and Qu X: Research progress
of adverse events related to PD-1/PD-L1 inhibitors based
combination therapy. Zhongguo Fei Ai Za Zhi. 24:513–518. 2021.(In
Chinese). PubMed/NCBI
|
|
17
|
Sung SY, Hsieh CL, Wu D, Chung LWK and
Johnstone PAS: Tumor microenvironment promotes cancer progression,
metastasis, and therapeutic resistance. Curr Probl Cancer.
31:36–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tung JC, Barnes JM, Desai SR, Sistrunk C,
Conklin MW, Schedin P, Eliceiri KW, Keely PJ, Seewaldt VL and
Weaver VM: Tumor mechanics and metabolic dysfunction. Free Radic
Biol Med. 79:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xian J, Xiao F, Zou J, Luo W, Han S, Liu
Z, Chen Y, Zhu Q, Li M, Yu C, et al: Elemene hydrogel modulates the
tumor immune microenvironment for enhanced treatment of
postoperative cancer recurrence and metastases. J Am Chem Soc.
146:35252–35263. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang N, Gao H, He L, Liu Y, Fan H, Xu Q
and Yang S: Ginsenoside Rb1 is an immune-stimulatory agent with
antiviral activity against enterovirus 71. J Ethnopharmacol.
266:1134012021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang W, Jia M, Lian J, Lu S, Zhou J, Fan
Z, Zhu Z, He Y, Huang C, Zhu M, et al: Inhibition of TANK-binding
kinase1 attenuates the astrocyte-mediated neuroinflammatory
response through YAP signaling after spinal cord injury. CNS
Neurosci Ther. 29:2206–2222. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, He Y, Zhu J, Zhao S, Qi S, Chen X,
Zhang H, Ni Z, Zhou Y, Chen G, et al: The roles and mechanism of
m6A RNA methylation regulators in cancer immunity.
Biomed Pharmacother. 163:1148392023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu J, Yang Q, Yue Z, Liao B, Cheng H, Li
W, Zhang H, Wang S and Tian Q: Emerging advances in engineered
macrophages for tumor immunotherapy. Cytotherapy. 25:235–244. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Q, Luo Q, Ju Y and Song G: Role of the
mechanical microenvironment in cancer development and progression.
Cancer Biol Med. 17:282–292. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shieh AC: Biomechanical forces shape the
tumor microenvironment. Ann Biomed Eng. 39:1379–1389. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mbeunkui F and Johann DJ Jr: Cancer and
the tumor microenvironment: A review of an essential relationship.
Cancer Chemother Pharmacol. 63:571–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raudenská M, Navrátil J, Gumulec J and
Masařík M: Mechanobiology of cancerogenesis. Klin Onkol.
34:202–210. 2021.PubMed/NCBI
|
|
28
|
Butcher DT, Alliston T and Weaver VM: A
tense situation: Forcing tumour progression. Nat Rev Cancer.
9:108–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution. Curr
Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hamill OP and Martinac B: Molecular basis
of mechanotransduction in living cells. Physiol Rev. 81:685–740.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ghosh D and Dawson MR: Microenvironment
influences cancer cell mechanics from tumor growth to metastasis.
Adv Exp Med Biol. 1092:69–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kumar S and Weaver VM: Mechanics,
malignancy, and metastasis: The force journey of a tumor cell.
Cancer Metastasis Rev. 28:113–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Frey B, Janko C, Ebel N, Meister S,
Schlücker E, Meyer-Pittroff R, Fietkau R, Herrmann M and Gaipl US:
Cells under pressure-treatment of eukaryotic cells with high
hydrostatic pressure, from physiologic aspects to pressure induced
cell death. Curr Med Chem. 15:2329–2336. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Patterson MF: Microbiology of
pressure-treated foods. J Appl Microbiol. 98:1400–1409. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao LP, Hu JH, Hu D, Wang HJ, Huang CG,
Luo RH, Zhou ZH, Huang XY, Xie T and Lou JS: Hyperprogression, a
challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms
and coping strategies. Biomed Pharmacother. 150:1129492022.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moserova I, Truxova I, Garg AD, Tomala J,
Agostinis P, Cartron PF, Vosahlikova S, Kovar M, Spisek R and
Fucikova J: Caspase-2 and oxidative stress underlie the immunogenic
potential of high hydrostatic pressure-induced cancer cell death.
Oncoimmunology. 6:e12585052017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fucikova J, Moserova I, Truxova I,
Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron
PF, Houska M, et al: High hydrostatic pressure induces immunogenic
cell death in human tumor cells. Int J Cancer. 135:1165–1177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rozková D, Tiserová H, Fucíková J,
Last'ovicka J, Podrazil M, Ulcová H, Budínský V, Prausová J, Linke
Z, Minárik I, et al: FOCUS on FOCIS: Combined chemo-immunotherapy
for the treatment of hormone-refractory metastatic prostate cancer.
Clin Immunol. 131:1–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang F and Jiang RM: Negative pressure
may become a new method for treatment of malignancies. J Air Force
Med Univ. 43:120–122. 2022.(In Chinese).
|
|
40
|
Yang X, Sun B, Zhu H and Jiang Z:
Suppression effects of negative pressure on the proliferation and
metastasis in human pancreatic cancer cells. J Cancer Res Ther.
11:195–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lallow EO, Jhumur NC, Ahmed I, Kudchodkar
SB, Roberts CC, Jeong M, Melnik JM, Park SH, Muthumani K, Shan JW,
et al: Novel suction-based in vivo cutaneous DNA transfection
platform. Sci Adv. 7:eabj06112021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Szelényi Z and Komoly S: Thermoregulation:
From basic neuroscience to clinical neurology, part 2. Temperature
(Austin). 6:7–10. 2018. View Article : Google Scholar
|
|
43
|
Vertree RA, Leeth A, Girouard M, Roach JD
and Zwischenberger JB: Whole-body hyperthermia: A review of theory,
design and application. Perfusion. 17:279–290. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chia BSH, Ho SZ, Tan HQ, Chua MLK and Tuan
JKL: A review of the current clinical evidence for loco-regional
moderate hyperthermia in the adjunct management of cancers. Cancers
(Basel). 15:3462023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kok HP, Cressman ENK, Ceelen W, Brace CL,
Ivkov R, Grüll H, Ter Haar G, Wust P and Crezee J: Heating
technology for malignant tumors: A review. Int J Hyperthermia.
37:711–741. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hildebrandt B, Wust P, Ahlers O, Dieing A,
Sreenivasa G, Kerner T, Felix R and Riess H: The cellular and
molecular basis of hyperthermia. Crit Rev Oncol Hematol. 43:33–56.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ito A, Shinkai M, Honda H, Wakabayashi T,
Yoshida J and Kobayashi T: Augmentation of MHC class I antigen
presentation via heat shock protein expression by hyperthermia.
Cancer Immunol Immunother. 50:515–522. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen C, Ren A, Yi Q, Cai J, Khan M, Lin Y,
Huang Z, Lin J, Zhang J, Liu W, et al: Therapeutic hyperthermia
regulates complement C3 activation and suppresses tumor development
through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma. Clin
Exp Immunol. 213:221–234. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Paulson JR, Luedtke RL, Suydam S, Obi D
and Xie L: ABT-263, an inhibitor of Bcl-2 family antiapoptotic
proteins, sensitizes prometaphase-arrested HeLa cells to apoptosis
induced by mild hyperthermia. Int J Biochem Res Rev. 31:23–34.
2022. View Article : Google Scholar
|
|
50
|
Dillon MT, Good JS and Harrington KJ:
Selective targeting of the G2/M cell cycle checkpoint to improve
the therapeutic index of radiotherapy. Clin Oncol (R Coll Radiol).
26:257–265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hatamian M, Hashemi B, Mahdavi SR,
Soleimani M and Khalafi L: Effect of 13.56 MHz radiofrequency
hyperthermia on mitotic cell cycle arrest in MCF7 breast cancer
cell line and suggest a time interval for radiotherapy. J Cancer
Res Ther. 19:447–451. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu S, Hui Z, Lirussi F, Garrido C, Ye XY
and Xie T: Small molecule DNA-PK inhibitors as potential cancer
therapy: A patent review (2010-present). Expert Opin Ther Pat.
31:435–452. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
van Oorschot B, Granata G, Di Franco S,
Ten Cate R, Rodermond HM, Todaro M, Medema JP and Franken NA:
Targeting DNA double strand break repair with hyperthermia and
DNA-PKcs inhibition to enhance the effect of radiation treatment.
Oncotarget. 7:65504–65513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Goldstein M and Kastan MB: The DNA damage
response: Implications for tumor responses to radiation and
chemotherapy. Annu Rev Med. 66:129–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liang X, Zhou H, Liu X, He Y, Tang Y, Zhu
G, Zheng M and Yang J: Effect of local hyperthermia on
lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft
model of tongue squamous cell carcinoma. Oral Oncol. 46:111–115.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Razavi R and Harrison LE: Thermal
sensitization using induced oxidative stress decreases tumor growth
in an in vivo model of hyperthermic intraperitoneal perfusion. Ann
Surg Oncol. 17:304–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Datta NR, Ordóñez SG, Gaipl US, Paulides
MM, Crezee H, Gellermann J, Marder D, Puric E and Bodis S: Local
hyperthermia combined with radiotherapy and-/or chemotherapy:
Recent advances and promises for the future. Cancer Treat Rev.
41:742–753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Baust JG, Snyder KK, Santucci KL,
Robilotto AT, Van Buskirk RG and Baust JM: Cryoablation: Physical
and molecular basis with putative immunological consequences. Int J
Hyperthermia. 36 (Suppl 1):S10–S16. 2019. View Article : Google Scholar
|
|
59
|
Wen J, Duan Y, Zou Y, Nie Z, Feng H,
Lugnani F and Baust JG: Cryoablation induces necrosis and apoptosis
in lung adenocarcinoma in mice. Technol Cancer Res Treat.
6:635–640. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen Z, Meng L, Zhang J and Zhang X:
Progress in the cryoablation and cryoimmunotherapy for tumor. Front
Immunol. 14:10940092023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shao Q, O'Flanagan S, Lam T, Roy P, Pelaez
F, Burbach BJ, Azarin SM, Shimizu Y and Bischof JC: Engineering T
cell response to cancer antigens by choice of focal therapeutic
conditions. Int J Hyperthermia. 36:130–138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wu Y, Cao F, Zhou D, Chen S, Qi H, Huang
T, Tan H, Shen L and Fan W: Cryoablation reshapes the immune
microenvironment in the distal tumor and enhances the anti-tumor
immunity. Front Immunol. 13:9304612022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Seki T, Yang Y, Sun X, Lim S, Xie S, Guo
Z, Xiong W, Kuroda M, Sakaue H, Hosaka K, et al: Brown-fat-mediated
tumour suppression by cold-altered global metabolism. Nature.
608:421–428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Guo RQ, Guo XX, Li YM, Bie ZX, Li B and Li
XG: Cryoablation, high-intensity focused ultrasound, irreversible
electroporation, and vascular-targeted photodynamic therapy for
prostate cancer: A systemic review and meta-analysis. Int J Clin
Oncol. 26:461–484. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kurz B, Berneburg M, Bäumler W and Karrer
S: Phototherapy: Theory and practice. J Dtsch Dermatol Ges.
21:882–897. 2023. View Article : Google Scholar
|
|
66
|
Li X, Lovell JF, Yoon J and Chen X:
Clinical development and potential of photothermal and photodynamic
therapies for cancer. Nat Rev Clin Oncol. 17:657–674. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang X, Zhang H, Wu Z, Chen Q, Zheng W,
Shen Q, Wei Q, Shen JW and Guo Y: Tumor therapy utilizing
dual-responsive nanoparticles: A multifaceted approach integrating
calcium-overload and PTT/CDT/chemotherapy. J Control Release.
376:646–658. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Vankayala R and Hwang KC:
Near-infrared-light-activatable nanomaterial-mediated
phototheranostic nanomedicines: An emerging paradigm for cancer
treatment. Adv Mater. 30:e17063202018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ali MRK, Ibrahim IM, Ali HR, Selim SA and
El-Sayed MA: Treatment of natural mammary gland tumors in canines
and felines using gold nanorods-assisted plasmonic photothermal
therapy to induce tumor apoptosis. Int J Nanomedicine.
11:4849–4863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pérez-Hernández M, Del Pino P, Mitchell
SG, Moros M, Stepien G, Pelaz B, Parak WJ, Gálvez EM, Pardo J and
de la Fuente JM: Dissecting the molecular mechanism of apoptosis
during photothermal therapy using gold nanoprisms. ACS Nano.
9:52–61. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wang S, Li L, Ning X, Xue P and Liu Y:
pH-activated heat shock protein inhibition and radical generation
enhanced NIR luminescence imaging-guided photothermal tumour
ablation. Int J Pharm. 566:40–45. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Deng X, Guan W, Qing X, Yang W, Que Y, Tan
L, Liang H, Zhang Z, Wang B, Liu X, et al: Ultrafast
low-temperature photothermal therapy activates autophagy and
recovers immunity for efficient antitumor treatment. ACS Appl Mater
Interfaces. 12:4265–4275. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhao P, Zheng M, Yue C, Luo Z, Gong P, Gao
G, Sheng Z, Zheng C and Cai L: Improving drug accumulation and
photothermal efficacy in tumor depending on size of ICG loaded
lipid-polymer nanoparticles. Biomaterials. 35:6037–6046. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nam J, Son S, Ochyl LJ, Kuai R,
Schwendeman A and Moon JJ: Chemo-photothermal therapy combination
elicits anti-tumor immunity against advanced metastatic cancer. Nat
Commun. 9:10742018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li T, Ashrafizadeh M, Shang Y, Nuri Ertas
Y and Orive G: Chitosan-functionalized bioplatforms and hydrogels
in breast cancer: Immunotherapy, phototherapy and clinical
perspectives. Drug Discov Today. 29:1038512024. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Castano AP, Mroz P and Hamblin MR:
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer.
6:535–545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tian R, Sun W, Li M, Long S, Li M, Fan J,
Guo L and Peng X: Development of a novel anti-tumor theranostic
platform: A near-infrared molecular upconversion sensitizer for
deep-seated cancer photodynamic therapy. Chem Sci. 10:10106–10112.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu YQ, Meng PS, Zhang HC, Liu X, Wang MX,
Cao WW, Hu Z and Zhang ZG: Inhibitory effect of aloe emodin
mediated photodynamic therapy on human oral mucosa carcinoma in
vitro and in vivo. Biomed Pharmacother. 97:697–707. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
de Miguel GC, Abrantes AM, Laranjo M,
Grizotto AYK, Camporeze B, Pereira JA, Brites G, Serra A, Pineiro
M, Rocha-Gonsalves A, et al: A new therapeutic proposal for
inoperable osteosarcoma: Photodynamic therapy. Photodiagnosis
Photodyn Ther. 21:79–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Krupka M, Bartusik-Aebisher D, Strzelczyk
N, Latos M, Sieroń A, Cieślar G, Aebisher D, Czarnecka M,
Kawczyk-Krupka A and Latos W: The role of autofluorescence,
photodynamic diagnosis and Photodynamic therapy in malignant tumors
of the duodenum. Photodiagnosis Photodyn Ther. 32:1019812020.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Dolmans DEGJ, Kadambi A, Hill JS, Waters
CA, Robinson BC, Walker JP, Fukumura D and Jain RK: Vascular
accumulation of a novel photosensitizer, MV6401, causes selective
thrombosis in tumor vessels after photodynamic therapy. Cancer Res.
62:2151–2156. 2002.PubMed/NCBI
|
|
83
|
Zhao Y, Zhao Y, Ma Q, Zhang H, Liu Y, Hong
J, Ding Z, Liu M and Han J: Novel carrier-free nanoparticles
composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6:
Self-assembly mechanism investigation and in vitro/in vivo
evaluation. Colloids Surf B Biointerfaces. 188:1107222020.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liu C, Sun S, Feng Q, Wu G, Wu Y, Kong N,
Yu Z, Yao J, Zhang X, Chen W, et al: Arsenene nanodots with
selective killing effects and their low-dose combination with
ß-elemene for cancer therapy. Adv Mater. 33:e21020542021.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zheng Y, Yin G, Le V, Zhang A, Chen S,
Liang X and Liu J: Photodynamic-therapy activates immune response
by disrupting immunity homeostasis of tumor cells, which generates
vaccine for cancer therapy. Int J Biol Sci. 12:120–132. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lee JY, Diaz RR, Cho KS, Lim MS, Chung JS,
Kim WT, Ham WS and Choi YD: Efficacy and safety of photodynamic
therapy for recurrent, high grade nonmuscle invasive bladder cancer
refractory or intolerant to bacille Calmette-Guérin immunotherapy.
J Urol. 190:1192–1199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Correia JH, Rodrigues JA, Pimenta S, Dong
T and Yang Z: Photodynamic therapy review: Principles,
photosensitizers, applications, and future directions.
Pharmaceutics. 13:13322021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Chen W, Liu C, Ji X, Joseph J, Tang Z,
Ouyang J, Xiao Y, Kong N, Joshi N, Farokhzad OC, et al:
Stanene-based nanosheets for β-elemene delivery and
ultrasound-mediated combination cancer therapy. Angew Chem Int Ed
Engl. 60:7155–7164. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Li E, Sun Y, Lv G, Li Y, Zhang Z, Hu Z and
Cao W: Sinoporphyrin sodium based sonodynamic therapy induces
anti-tumor effects in hepatocellular carcinoma and activates
p53/caspase 3 axis. Int J Biochem Cell Biol. 113:104–114. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Yang W, Xu H, Liu Q, Liu C, Hu J, Liu P,
Fang T, Bai Y, Zhu J and Xie R: 5-Aminolevulinic acid hydrochloride
loaded microbubbles-mediated sonodynamic therapy in pancreatic
cancer cells. Artif Cells Nanomed Biotechnol. 48:1178–1188. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Hong X, Huang S, Jiang H, Ma Q, Qiu J, Luo
Q, Cao C, Xu Y, Chen F, Chen Y, et al: Alcohol-related liver
disease (ALD): Current perspectives on pathogenesis, therapeutic
strategies, and animal models. Front Pharmacol. 15:14324802024.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhang R, Pan T, Xiang Y, Zhang M, Feng J,
Liu S, Duan T, Chen P, Zhai B, Chen X, et al: β-Elemene reverses
the resistance of p53-deficient colorectal cancer cells to
5-fluorouracil by inducing pro-death autophagy and cyclin
D3-dependent cycle arrest. Front Bioeng Biotechnol. 8:3782020.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhang R, Zheng Y, Zhu Q, Gu X, Xiang B, Gu
X, Xie T and Sui X: β-Elemene reverses gefitinib resistance in
NSCLC cells by inhibiting lncRNA H19-mediated autophagy.
Pharmaceuticals (Basel). 17:6262024. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen F, Xue Q, He N, Zhang X, Li S and
Zhao C: The association and application of sonodynamic therapy and
autophagy in diseases. Life Sci. 334:1222152023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kong N, Chen X, Feng J, Duan T, Liu S, Sun
X, Chen P, Pan T, Yan L, Jin T, et al: Baicalin induces ferroptosis
in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B.
11:4045–4054. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Sun N, Lei Q, Wu M, Gao S, Yang Z, Lv X,
Wei R, Yan F and Cai L: Metal-organic framework-mediated siRNA
delivery and sonodynamic therapy for precisely triggering
ferroptosis and augmenting ICD in osteosarcoma. Mater Today Bio.
26:1010532024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Inui T, Amitani H, Kubo K, Kuchiike D, Uto
Y, Nishikata T and Mette M: Case report: A non-small cell lung
cancer patient treated with GcMAF, sonodynamic therapy and tumor
treating fields. Anticancer Res. 36:3767–3770. 2016.PubMed/NCBI
|
|
98
|
Kulbacka J, Rembiałkowska N, Szewczyk A,
Rossowska J, Drąg-Zalesińska M, Kulbacki M and Choromańska A:
Nanosecond PEF induces oxidative stress and apoptosis via
proteasomal activity inhibition in gastric adenocarcinoma cells
with drug resistance. Int J Mol Sci. 23:129432022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Pastori C, Nafie EHO, Wagh MS,
Mammarappallil JG and Neal RE II: Pulsed electric field ablation
versus radiofrequency thermal ablation in murine breast cancer
models: Anticancer immune stimulation, tumor response, and abscopal
effects. J Vasc Interv Radiol. 35:442–451.e7. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Iannitti T, Fistetto G, Esposito A,
Rottigni V and Palmieri B: Pulsed electromagnetic field therapy for
management of osteoarthritis-related pain, stiffness and physical
function: Clinical experience in the elderly. Clin Interv Aging.
8:1289–1293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Vadalà M, Vallelunga A, Palmieri L,
Palmieri B, Morales-Medina JC and Iannitti T: Mechanisms and
therapeutic applications of electromagnetic therapy in Parkinson's
disease. Behav Brain Funct. 11:262015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Filipovic N, Djukic T, Radovic M,
Cvetkovic D, Curcic M, Markovic S, Peulic A and Jeremic B:
Electromagnetic field investigation on different cancer cell lines.
Cancer Cell Int. 14:842014. View Article : Google Scholar
|
|
103
|
Guo Y, Yang W, Pu G, Zhu C, Zhu Y, Li J,
Huang Y, Wang B and Chu M: Low frequency vibrating magnetic
field-triggered magnetic microspheres with a nanoflagellum-like
surface for cancer therapy. J Nanobiotechnology. 20:3162022.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Pantelis P, Theocharous G, Veroutis D,
Vagena IA, Polyzou A, Thanos DF, Kyrodimos E, Kotsinas A, Evangelou
K, Lagopati N, et al: Pulsed electromagnetic fields (PEMFs) trigger
cell death and senescence in cancer cells. Int J Mol Sci.
25:24732024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Barbault A, Costa FP, Bottger B, Munden
RF, Bomholt F, Kuster N and Pasche B: Amplitude-modulated
electromagnetic fields for the treatment of cancer: Discovery of
tumor-specific frequencies and assessment of a novel therapeutic
approach. J Exp Clin Cancer Res. 28:512009. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Ross C, Overholt T, Xu R, Badlani G, Evans
RJ, Matthews CA and Walker SJ: Pulsed electromagnetic field (PEMF)
as an adjunct therapy for pain management in interstitial
cystitis/bladder pain syndrome. Int Urogynecol J. 33:487–491. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Longhurst JC: Defining meridians: A modern
basis of understanding. J Acupunct Meridian Stud. 3:67–74. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Gümüş M, Chen CI, Ivanescu C, Kilickap S,
Bondarenko I, Özgüroğlu M, Gogishvili M, Turk HM, Cicin I, Harnett
J, et al: Patient-reported outcomes with cemiplimab monotherapy for
first-line treatment of advanced non-small cell lung cancer with
PD-L1 of ≥50%: The EMPOWER-lung 1 study. Cancer. 129:118–129. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Yu SG, Jing XH, Tang Y, Wu QF, Yin HY, Xie
LS, Zhao N, Lin SR and Chai XN: Acupuncture and moxibustion and
immunity: The actuality and future. Zhen Ci Yan Jiu. 43:747–753.
2018.(In Chinese). PubMed/NCBI
|
|
110
|
Hu D, Shen W, Gong C, Fang C, Yao C, Zhu
X, Wang L, Zhao C and Zhu S: Grain-sized moxibustion promotes NK
cell antitumour immunity by inhibiting adrenergic signalling in
non-small cell lung cancer. J Cell Mol Med. 25:2900–2908. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhang XJ, Lin JM, Chen SI, Lin CJ, Peng J,
Yang XD and Zhao JY: Electroacupuncture at ‘Zusanli(ST36)’
alleviates 5-fluorouracil-induced renal injury in colorectal
cancer-bearing mice by exerting effects on oxidative stress,
inflammatory responses, and cell apoptosis. World J Acupunct-Mox.
33:244–251. 2023. View Article : Google Scholar
|
|
112
|
Wang WZ, Wei XY, Yu DD, Du XY, Zhang C,
Wang JM and Han L: Mechanism of acupuncture and moxibustion
regulating TNF-α/TLR4/NF-κB in improving liver injury in cisplatin
mice. Modernization of Traditional Chinese Medicine and Materia
Medica-World Science and Technology. 25:1055–1060. 2023.(In
Chinese).
|
|
113
|
Yang YZ, Li SS, Guo Y, Huang J, Wang JQ,
Feng YT, Zhao SH, Zhao WJ and Xu ZF: Research progress of
acupuncture and moxibustion for the enhanced synergism of
chemotherapy. Acupuncture Research. 49:634–640. 2024.(In Chinese).
PubMed/NCBI
|
|
114
|
Xing XR and Yin DF: Point injection
combined with acupuncture in patients with advanced malignancies
hiccup. Liaoning J Tradit Chin Med. 43:379–380. 2016.(In
Chinese).
|
|
115
|
Zhang XY: Clinical Study on Treatment of
Cancer Pain by External Application of Anti Cancer Analgesic
Plaster Combined with Acupuncture Three-Step Drug Analgesic Method.
Liaoning J Tradit Chin Med. 49:165–169. 2022.(In Chinese).
|
|
116
|
Wang TT, Cheng J, Wang J, Zou WJ and Song
N: Effect of acupuncture treating cancer-related insomnia: A
systematic review. Liaoning. J Tradit Chin Med. 50:196–201+257.
2023.(In Chinese).
|
|
117
|
Zhao JX and Li J: Action and
characteristic of acupuncture and moxibustion in treatment of
malignant tumor. J Clin Acupunct Moxibustion. 38:99–103. 2022.(In
Chinese).
|
|
118
|
Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T,
Ting R, Zhang J and An F: Hypoxia-activated nanomedicines for
effective cancer therapy. Eur J Med Chem. 195:1122742020.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Cortes AC, Nishiofuku H, Polak U, Minhaj
AA, Lopez MS, Kichikawa K, Qayyum A, Whitley EM and Avritscher R:
Effect of bead size and doxorubicin loading on tumor cellular
injury after transarterial embolization and chemoembolization in a
rat model of hepatocellular carcinoma. Nanomedicine. 39:1024652022.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Avritscher R, Jo N, Polak U, Cortes AC,
Nishiofuku H, Odisio BC, Takaki H, Tam AL, Melancon MP, Yevich S,
et al: Hepatic arterial bland embolization increases Th17 cell
infiltration in a syngeneic rat model of hepatocellular carcinoma.
Cardiovasc Intervent Radiol. 43:311–321. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Maclean D, Vigneswaran G, Bryant T, Modi S
and Hacking N: A retrospective cohort study comparing a novel,
spherical, resorbable particle against five established embolic
agents for uterine fibroid embolisation. Clin Radiol. 76:452–457.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhang J, Wu N, Lian Z, Feng H, Jiang Q,
Chen X, Gong J and Qiao Z: The combined antitumor effects of
125I radioactive particle implantation and
cytokine-induced killer cell therapy on xenograft hepatocellular
carcinoma in a mouse model. Technol Cancer Res Treat. 16:1083–1091.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Kandzari DE, Weber MA, Pathak A, Zidar JP,
Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, et
al: Effect of alcohol-mediated renal denervation on blood pressure
in the presence of antihypertensive medications: Primary results
from the TARGET BP I randomized clinical trial. Circulation.
149:1875–1884. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Pyszora A, Budzyński J, Wójcik A, Prokop A
and Krajnik M: Physiotherapy programme reduces fatigue in patients
with advanced cancer receiving palliative care: Randomized
controlled trial. Support Care Cancer. 25:2899–2908. 2017.
View Article : Google Scholar : PubMed/NCBI
|
